State Of Wyoming Igm Biosciences, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $16,242 - $31,212	-1,224 Reduced 81.98%	269 $5,000
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $6,616 - $14,656	493 Added 49.3%	1,493 $40,000
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $4,193 - $10,091	152 Added 17.92%	1,000 $29,000
Q3 2021 Feb 11, 2022	SELL	$65.76 - $90.65 $30,644 - $42,242	-466 Reduced 35.46%	848 $56,000
Q2 2021 Feb 11, 2022	BUY	$57.98 - $96.6 $44,934 - $74,865	775 Added 143.78%	1,314 $109,000
Q1 2021 Feb 08, 2022	BUY	$71.56 - $121.23 $38,570 - $65,342	539 New	539 $41,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.